Related references
Note: Only part of the references are listed.
Article
Public, Environmental & Occupational Health
Kiersten J. Kugeler et al.
Summary: Testing residual clinical specimens provided a similar seroprevalence estimate yet yielded limited insight into the local epidemiology of COVID-19 and might be less representative of the source population than a cluster-sampled community survey. Awareness of the limitations of various sampling strategies is necessary when interpreting findings from seroprevalence assessments.
PUBLIC HEALTH REPORTS
(2022)
Article
Immunology
Alexia Couture et al.
Summary: Case-based surveillance underestimates pediatric SARS-CoV-2 infections. Estimated numbers of pediatric SARS-CoV-2 infections were higher than reported cases.
OPEN FORUM INFECTIOUS DISEASES
(2022)
Article
Medicine, General & Internal
Zheng Quan Toh et al.
Summary: This cohort study found that children with mild SARS-CoV-2 infection were less likely to have seroconversion compared to adults, despite similar viral loads. This has implications for understanding protection and interpreting serosurveys involving children.
Article
Medicine, General & Internal
Carlota Dobano et al.
Summary: This study evaluated the persistence of SARS-CoV-2 antibodies in a cohort of 247 primary health care workers from Barcelona, Spain, up to 616 days since the onset of symptoms. The study found a gradual decline in antibody levels over time but maintained a seropositivity rate of over 90% for five SARS-CoV-2 antigens. Factors such as age, comorbidities, and occupation were associated with antibody levels.
Letter
Pediatrics
Chee Fu Yung et al.
Summary: This study evaluates the presence of neutralizing antibodies in the serum samples of children in different age groups during and after SARS-CoV-2 infection.
Article
Medical Laboratory Technology
Danyel H. Tacker et al.
Summary: The College of American Pathologists conducted a survey on the performance of anti-SARS-CoV-2 antibody assays, showing high agreement in qualitative results for IgG and total antibodies across most participating clinical laboratories. However, there were inconsistencies in the qualitative results for IgM and IgA.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
(2021)
Review
Pediatrics
Danielle A. Rankin et al.
Summary: In the United States, the majority of SARS-CoV-2 infections in children have been mild, with the highest frequency among children aged 5-17 years. Although older children have higher case counts, infants under one year old have also been hospitalized. Clinical manifestations of SARS-CoV-2 infection in children range from asymptomatic to severe respiratory distress, with some children experiencing medical complications and death.
CURRENT OPINION IN PEDIATRICS
(2021)
Article
Public, Environmental & Occupational Health
Roma Thamm et al.
Summary: Serologic studies on SARS-CoV-2 prevalence in children and adolescents in Germany show that during the first wave of COVID-19, the seroprevalence was below 1% for preschool and elementary school children and below 2% for adolescents. However, as the pandemic progressed, seroprevalence rates as high as 8% were found in elementary school children. Future research should focus on estimating the proportion of children and adolescents who have been infected or vaccinated, as well as investigating health impairments post-infection.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ
(2021)
Article
Immunology
Maren J. H. Rytter et al.
Summary: In Denmark, a cross-sectional study found similar low rates of SARS-CoV-2 antibodies in children visiting pediatric departments and blood donors, suggesting that both children and adults were infected at a similar low degree.
PEDIATRIC INFECTIOUS DISEASE JOURNAL
(2021)
Article
Pediatrics
Burkhard Toenshoff et al.
Summary: A study conducted in southwest Germany showed that the rate of SARS-CoV-2 infections was low among children aged 1 to 10, suggesting that they are unlikely to have significantly contributed to the pandemic. Large-scale testing provides a basis for informed political decision-making during a pandemic.
Letter
Immunology
Jan Van Elslande et al.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Pediatrics
Lynn C. Smitherman et al.
PEDIATRIC CLINICS OF NORTH AMERICA
(2021)
Article
Public, Environmental & Occupational Health
Charlotte V. Hobbs et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2021)
Article
Pediatrics
Erika Molteni et al.
Summary: Most school-aged children in the UK with SARS-CoV-2 infection are asymptomatic or experience mild illness, with longer duration and higher symptom burden observed in older children. Persistence of illness is more common in older children, but symptom burden does not increase over time and most recover within 56 days. Children who test negative for SARS-CoV-2 may also experience prolonged illness with higher symptom burden.
LANCET CHILD & ADOLESCENT HEALTH
(2021)
Article
Medicine, General & Internal
Kate Zinszer et al.
Summary: This study aimed to estimate the seroprevalence of SARS-CoV-2 antibodies in children and teenagers in 4 neighborhoods of Montreal, Canada. The results indicate a higher level of transmission in children compared to what was detected by RT-PCR, with most cases experiencing mild or no symptoms.
Article
Public, Environmental & Occupational Health
Katerina Brandt et al.
Summary: The analysis of SARS-CoV-2 testing data in North Carolina revealed disparities in access to COVID-19 testing across racial-ethnic groups, particularly among Latinx, NL Black, and other historically marginalized populations. Additionally, people living in rural areas showed higher test positivity rates across all racial-ethnic groups.
Article
Public, Environmental & Occupational Health
Laura Espenhain et al.
Summary: Seroprevalence studies conducted in Denmark in 2020 have shown an increase in seroprevalence estimates throughout the year, especially in the 12-29 age group and metropolitan areas. Hospitalization rates were significantly higher in older age groups, and although many seropositive individuals were asymptomatic, loss of taste/smell was a specific symptom.
EUROPEAN JOURNAL OF EPIDEMIOLOGY
(2021)
Article
Gastroenterology & Hepatology
Elizabeth A. Spencer et al.
INFLAMMATORY BOWEL DISEASES
(2021)
Article
Medicine, General & Internal
Jefferson M. Jones et al.
Summary: A study based on blood donations in the US from July 2020 to May 2021 found that seroprevalence of SARS-CoV-2 antibodies induced by vaccination or infection increased over time and varied by age, race and ethnicity, and geographic region. Despite adjustments for demographic differences, the findings may not be fully representative of the entire US population.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Article
Multidisciplinary Sciences
Natalia Ortega et al.
Summary: Long-term kinetics of antibodies to SARS-CoV-2 were examined in a cohort of health care workers, showing stable levels over time with an increase in anti-spike antibody levels around 150 days post-symptom onset. Additionally, asymptomatic individuals had significantly higher levels of IgG and IgA to HCoV compared to symptomatic individuals, suggesting a potential protective effect of pre-existing cross-reactive HCoVs antibodies against SARS-CoV-2 infection and COVID-19 disease.
NATURE COMMUNICATIONS
(2021)
Article
Multidisciplinary Sciences
Katy A. M. Gaythorpe et al.
Summary: The study conducted a systematic review on the impact of SARS-CoV-2 infection, severity, and transmissibility in children during the COVID-19 pandemic. The results showed that compared to adults, there is still uncertainty regarding children's susceptibility and transmissibility, but most children experience milder symptoms or remain asymptomatic. Comprehensive contact-tracing studies are needed to further understand the role of children in the pandemic.
SCIENTIFIC REPORTS
(2021)
Article
Pediatrics
Defne Saatci et al.
Summary: This study investigated the association between race and childhood COVID-19 testing and hospital outcomes. It found that there were some race-specific disparities in severe COVID-19 outcomes among children in England.
Article
Multidisciplinary Sciences
Michael J. Peluso et al.
Summary: Interpretation of SARS-CoV-2 serosurveillance studies is constrained by varied performance of antibody assays based on disease severity, timing, and type of assay used. Antibody responses were consistently lower in individuals with mild infection, with sensitivity of commercial assays ranging widely. These findings highlight the importance of considering these factors in the design and interpretation of serosurveillance studies.
Article
Medicine, General & Internal
Floriane Gallais et al.
Summary: The study revealed a triphasic kinetic model of SARS-CoV-2 antibodies in convalescent individuals, showing long-term persistence and reduced risk of reinfection. Vaccination significantly increased antibody titers, enhancing protection against variants.
Article
Microbiology
Maya W. Keuning et al.
Summary: Understanding the heterogeneity of SARS-CoV-2 antibodies in children is crucial for future public health and vaccine strategies. Our study demonstrates the additional value of saliva antibody detection next to detection of antibodies in serum, highlighting the heterogeneity of SARS-CoV-2 antibodies in terms of antigen specificity and differences between circulating and mucosal antibodies.
MICROBIOLOGY SPECTRUM
(2021)
Article
Immunology
Weimin Liu et al.
Summary: Not all individuals recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. Factors associated with non-seroconversion include younger age and higher reverse transcription PCR cycle threshold values, with viral loads in the nasopharynx identified as a major correlate of the systemic antibody response.
EMERGING INFECTIOUS DISEASES
(2021)
Article
Pediatrics
Manola Comar et al.
Summary: In a study conducted in January 2021 in Trieste, Italy, a 9.5% prevalence of SARS-CoV-2 infection was found in a pediatric cohort, showing a significant increase compared to the 1% prevalence observed in July 2020.
ITALIAN JOURNAL OF PEDIATRICS
(2021)
Article
Immunology
Stuart P. Weisberg et al.
Summary: This study found distinct antibody responses in children and adults after SARS-CoV-2 infection. Adult COVID-19 cohorts showed a broader range of antibody responses, while children predominantly generated antibodies specific for the S protein and had reduced neutralizing activity compared to adults.
Article
Virology
Craig Fenwick et al.
Summary: In this study, antibody responses to SARS-CoV-2 were evaluated in acute and postinfection subjects. The results show that responses against viral S and N proteins were equally sensitive in acute phase, but N responses decreased in postinfection phase while S responses persisted. The most sensitive assay used the native S protein trimer, suggesting its importance in estimating SARS-CoV-2 infections and assessing vaccine-induced responses.
JOURNAL OF VIROLOGY
(2021)
Review
Immunology
Nisha S. Mehta et al.
CLINICAL INFECTIOUS DISEASES
(2020)
Article
Public, Environmental & Occupational Health
Stephanie Bialek et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2020)
Article
Pediatrics
Yuanyuan Dong et al.
Article
Immunology
Petra Zimmermann et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL
(2020)
Article
Pediatrics
Monika K. Goyal et al.
Article
Pathology
Phoebe C. M. Williams et al.
Article
Public, Environmental & Occupational Health
Cheryl L. Gibbons et al.
